Another approach for improving antitumor virus therapy efficiency involves insertion of the GM-CSF encoding gene into an MV genome.156 In the colon adenocarcinoma model, it was demonstrated that the MV construct significantly delayed tumor progression and prolonged median overall survival of treated animals. This evidence concerns the gene CSF2 and neoplasm.